Last reviewed · How we verify
YR001 ointment
At a glance
| Generic name | YR001 ointment |
|---|---|
| Sponsor | Hangzhou Yirui Pharmaceutical Technology Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis (PHASE2)
- A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- YR001 ointment CI brief — competitive landscape report
- YR001 ointment updates RSS · CI watch RSS
- Hangzhou Yirui Pharmaceutical Technology Co., Ltd portfolio CI